# DESCRIPTION

## FIELD OF THE INVENTION

- relate to pharmaceutical formulations for vaginal administration

## BACKGROUND

- describe vaginal microbiome and its imbalance
- discuss vulvovaginal candidosis and its treatment

## SUMMARY

- introduce pharmaceutical formulation for vaginal administration
- describe composition and advantages of glucono δ-lactone

## DETAILED DESCRIPTION OF THE INVENTION

- introduce biofilm formation in vulvovaginal Candida infections
- describe importance of biofilm assay in evaluating effect of hydroxylated carboxylic acid
- discuss effect of lactic acid on biofilm formation
- describe surprising effect of polyhydroxylated C6 carboxylic acids on biofilm formation
- discuss mechanism of action of polyhydroxylated C6 carboxylic acids
- introduce glucono-δ-lactone as active compound
- describe pharmaceutical formulation comprising glucono-δ-lactone
- discuss excipients and pH-adjusting agents in pharmaceutical formulation
- describe release of glucono-δ-lactone over extended period of time
- outline use of pharmaceutical formulation in prevention and treatment of urogenital fungal infections

### MATERIALS AND METHODS

- describe biofilm formation assay and yeast strains used

### Examples

- demonstrate GDA effects on biofilm formation and viability
- illustrate GDA's pH-dependent hydrolysis and biofilm prevention

